Medical News

RSS

Corventis' AVIVO Mobile Patient Management System receives the CE mark

Corventis, Inc., a developer of wireless cardiovascular solutions designed to enable early detection, prevention and treatment of cardiovascular conditions, announced CE marking for the company’s AVIVO™ Mobile Patient Management System. Physicians and patients in the European Union and other countries that accept CE Mark now have access to the company’s noninvasive, wireless solution to evaluate physiological changes and monitor signs of cardiac irregularities in patients away from the hospital.

14 Sep 2009

ALR Technologies receives patent application approval for its Health-E-Connect communications system

ALR Technologies (OTCBB: ALRT) announces that it has received notice from the US Patent and Trademark Office that ALRT has been granted approval of its patent application regarding patient compliance and remote monitoring of patient's use of nebulizer compressors.

14 Sep 2009

FDA clearance for PRO-STIM bone graft substitute

Wright Medical Group, Inc., a global orthopaedic medical device company, today announced the 510K clearance of PRO-STIM™ Injectable Osteoinductive Bone Graft Substitute. PRO-STIM™ graft is a composite grafting material that is injected through a small needle, hardens, and is replaced by the patient’s new bone over time.

14 Sep 2009

'Tea Party' demonstrators march on Washington, protesting health care, taxes, government spending

The Associated Press: "Tens of thousands of protesters fed up with government spending marched to the U.S. Capitol on Saturday, showing their disdain for the president's health care plan with slogans such as 'Obamacare makes me sick' and 'I'm not your ATM.'

14 Sep 2009

Corventis completes enrollment for clinical trials of its MUSIC program

Corventis, Inc., a developer of wireless cardiovascular solutions designed to enable early detection, prevention and treatment of cardiovascular conditions, announced today enrollment completion of the company’s MUSIC (Multi-Sensor Monitoring in Congestive Heart Failure) program consisting of 2 trials: the MUSIC Asia (180 patients) and the pivotal MUSIC study (362 patients).

14 Sep 2009

Seniors most skeptical of health overhaul

Age plays a role in shaping people's thoughts on health care reform with seniors worried and confused about an overhaul.

14 Sep 2009

Enobia Pharma's clinical study of ENB-0040 for treating hypophosphatasia provides positive results

Enobia Pharma today announced positive data from a clinical study of ENB-0040, a bone targeted enzyme replacement therapy, under investigation for the treatment of hypophosphatasia (HPP). After six months of treatment with ENB-0040, four of five severely affected patients showed marked improvements in bone mineralization, correction of skeletal defects, better respiratory function, including weaning from assisted ventilation, and cognitive and motor development.

14 Sep 2009

Concept of wellness can yield greater savings

According to a new survey released today, 90 percent of plan sponsors believe that minimal attention to personal health and increased incidence of chronic illness such as diabetes and heart disease are at the root of rising health care costs.

14 Sep 2009

Celebrity joins breast cancer awareness campaign

Ricardo Antonio Chavira, star of ABC's hit TV show Desperate Housewives, found himself in a role he hoped never to play again - breast cancer caregiver. The diagnosis of his two sisters in late 2008 left Chavira shocked and overwhelmed with old memories of the challenges he experienced as a caregiver to his mother.

14 Sep 2009

Senator Bob Bennett speaks on healthcare at the UTC sponsored CEO Roundtable

Senator Bob Bennett recently discussed the state of the nation’s healthcare with a group of Utah CEOs at a CEO Roundtable sponsored by The Utah Technology Council (UTC), Utah’s premier technology and life science association.

14 Sep 2009

Career GPS program to help displaced biopharmaceutical professionals

BioAdvance, the University City Science Center and Wharton Small Business Development Center (SBDC) are collaborating to develop Career GPS, a program which is designed to help displaced biopharmaceutical professionals navigate the Greater Philadelphia region’s entrepreneurial career eco-system.

14 Sep 2009

HFSA annual meeting features discussion on David Duncan's quest for personalized medicine

The 13th Annual Scientific Meeting of the Heart Failure Society of America (HFSA) today featured a discussion by David Ewing Duncan titled "One Man's Quest for Personalized Medicine." Over the course of one year, Duncan submitted himself to hundreds of tests that could predict and even prevent future illness.

14 Sep 2009

IVIS Lumina XR in vivo imaging system from Caliper Life Sciences

Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life sciences research, today introduced the IVIS Lumina XR in vivo imaging system, the latest addition to the IVIS product family.

14 Sep 2009

Clinical study paper on TMR therapy with autologous stem cells presented

PLC Systems Inc., a company focused on innovative cardiac and vascular medical device-based technologies, today announced that a paper on a clinical study utilizing its Transmyocardial Laser Revascularization (TMR) therapy in conjunction with autologous stem cells was presented at ESC Congress 2009, the annual meeting of the European Society of Cardiology, in Barcelona, Spain.

14 Sep 2009

AirStrip Technologies to provide HIT solution to Premier healthcare alliance

The Premier healthcare alliance has contracted with AirStrip Technologies™, L.P. to offer its 2,200 hospitals members a mobile healthcare information technology (HIT) solution to improve obstetrical (OB) care, patient safety and communication among healthcare providers.

14 Sep 2009

Internet marketing program from AVVH

avVaa World Health Care Products Inc. (Pink Sheets: AVVH), a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products, announced today the launch of a major Internet marketing program.

14 Sep 2009

Protalix Biotherapeutics reports completion of its Phase III trial of prGCD

Protalix Biotherapeutics, Inc. (NYSE-Amex: PLX), announced the completion of its pivotal Phase III trial for prGCD, the Company’s proprietary plant-cell expressed recombinant form of glucocerebrosidase (GCD) for the treatment of Gaucher disease. The trial enrolled a total of 31 patients across Europe, North America, South America, Israel and South Africa. No serious adverse events were reported in this trial.

14 Sep 2009

Wash and dry hands to fight against H1N1

Countries around the world are trying to tackle the escalating H1N1 (swine flu) pandemic in different ways. Advice from all authorities, including the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC), remains the same: good hand hygiene, particularly in public places. Despite this, there are still too few people who know how to wash and dry their hands in the most hygienic way.

14 Sep 2009

Food preparation methods may put Canadians at risk of liver disease

As we head into the winter months, when locally grown food is less available and our fresh foods have to be imported, do you know just how far your food has travelled and what it may have picked up along the way?

14 Sep 2009

FDA approves St. Jude Medical's EnSite Velocity Cardiac Mapping System

St. Jude Medical, Inc. (NYSE: STJ) today announced U.S. Food and Drug Administration (FDA) clearance and U.S. launch of its EnSite Velocity™ Cardiac Mapping System. This new system has been designed to help physicians more efficiently diagnose and guide therapy to treat abnormal heart rhythms.

14 Sep 2009